Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novel cPLA2 inhibitors with antiinflammatory activity reported by Nippon Soda

March 26, 2001

Positive phase III results reported for Enbrel in psoriatic arthritic patients

March 26, 2001

Boehringer Ingelheim identifies new succinate cathepsin inhibitors

March 20, 2001

Novel antisense compounds as antiasthmatic, antiarthritic agents

March 19, 2001

Sumitomo presents new agents for immune and inflammatory disorders

March 16, 2001

Thrombin inhibition with PEG-hirudin as a new approach to the therapy of arthritis

March 16, 2001

SB-273005, an orally active vitronectin receptor antagonist with disease-modifying properties

March 15, 2001

Recombinant human C1 inhibitor enters trials for hereditary angioedema

March 12, 2001

Genmab reports encouraging results with HuMax-CD4 for RA

March 12, 2001

New series of antiinflammatory compounds in development at Merckle

March 9, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...